NPI: 1144297631 · BRANDON, FL 33511 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/02/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/02/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,652 | $2.36M |
| 2019 | 18,993 | $2.52M |
| 2020 | 22,035 | $3.03M |
| 2021 | 17,269 | $1.06M |
| 2022 | 11,262 | $382K |
| 2023 | 9,170 | $264K |
| 2024 | 2,629 | $153K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 33,549 | 2,133 | $4.24M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 28,203 | 1,437 | $2.27M |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,847 | 1,028 | $1.18M |
| A4657 | Syringe, with or without needle, each | 5,149 | 1,707 | $677K |
| J1756 | Injection, iron sucrose, 1 mg | 4,541 | 1,008 | $317K |
| 85041 | 1,650 | 1,098 | $180K | |
| 85048 | 1,651 | 1,098 | $180K | |
| 82728 | 1,397 | 929 | $171K | |
| 83540 | 1,398 | 918 | $165K | |
| 83550 | 1,326 | 884 | $163K | |
| 83970 | 1,323 | 864 | $161K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 595 | 335 | $49K |
| 82108 | 62 | 42 | $5K | |
| 90674 | 19 | 19 | $5K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 224 | 79 | $4K |
| G0008 | Administration of influenza virus vaccine | 29 | 27 | $4K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 21 | 13 | $3K |
| 82746 | 26 | 12 | $0.00 |